These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 13688926)

  • 21. [Pyrimidine- and purine-type antimetabolites].
    Skoda J
    Cas Lek Cesk; 1972 Nov; 111(45):1060-1. PubMed ID: 5084854
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapy of solid tumors.
    Alberto P
    Aktuelle Probl Chir; 1970; 14():807-34. PubMed ID: 4147168
    [No Abstract]   [Full Text] [Related]  

  • 23. Purine analogs as feedback inhibitors.
    GOTS JS; GOLLUB EG
    Proc Soc Exp Biol Med; 1959; 101():641-3. PubMed ID: 13851426
    [No Abstract]   [Full Text] [Related]  

  • 24. Data summaries of selected purine antagonists.
    Cancer Chemother Rep; 1961 Apr; 11():177-237. PubMed ID: 14447663
    [No Abstract]   [Full Text] [Related]  

  • 25. [Influencing the immune status of cancer patients through chemotherapy].
    Micksche M
    Wien Med Wochenschr; 1975 Dec; 125(50-52):729-35. PubMed ID: 779283
    [No Abstract]   [Full Text] [Related]  

  • 26. Advances in purine and pyrimidine metabolism in health and diseases.
    Hirano M; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):495-501. PubMed ID: 27906626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of some purines and purine-analogues on ascidian embryos.
    WADDINGTON CH; MANCUSO V
    Exp Cell Res; 1955 Oct; 9(2):369-71. PubMed ID: 13262054
    [No Abstract]   [Full Text] [Related]  

  • 28. Novel developments in metabolic disorders of purine and pyrimidine metabolism and therapeutic applications of their analogs.
    Torres RJ; Peters GJ; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):165-73. PubMed ID: 24940665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The present approach to systematic cancer therapy.
    Mukerjea DN; Koven BJ
    Indian J Cancer; 1970 Sep; 7(3):174-90. PubMed ID: 4927710
    [No Abstract]   [Full Text] [Related]  

  • 30. A colorimetric method for the determination of certain purine antagonists.
    LOO TL; MICHAEL ME
    J Biol Chem; 1958 May; 232(1):98-106. PubMed ID: 13549401
    [No Abstract]   [Full Text] [Related]  

  • 31. [Molecular mechanisms of the occurrence of tumor drug resistance and ways to overcome it].
    Belousova AK
    Vopr Onkol; 1978; 24(5):92-104. PubMed ID: 351956
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of purine antagonists on a diaminopurine-resistant strain of Lactobacillus casei.
    ELION GB; SINGER S; HITCHINGS GH; BALIS ME; DROWN GB
    J Biol Chem; 1953 Jun; 202(2):647-54. PubMed ID: 13061489
    [No Abstract]   [Full Text] [Related]  

  • 33. Properties of purine and pyrimidine analogs.
    Hitchings GH
    Adv Enzyme Regul; 1991; 31():433-43. PubMed ID: 1877398
    [No Abstract]   [Full Text] [Related]  

  • 34. CROSS RESISTANCE AND COLLATERAL SENSITIVITY STUDIES IN CANCER CHEMOTHERAPY.
    HUTCHISON DJ
    Adv Cancer Res; 1963; 7():235-50. PubMed ID: 14153767
    [No Abstract]   [Full Text] [Related]  

  • 35. THE MECHANISM OF ACTION OF PURINE AND PYRIMIDINE ANALOGS IN MICROORGANISMS.
    KEMPNER ES; MILLER JH
    Biochim Biophys Acta; 1963 Nov; 76():341-6. PubMed ID: 14097396
    [No Abstract]   [Full Text] [Related]  

  • 36. NORMAL VERSUS SYNCHRONIZED DIVISION IN TETRAHYMENA PYRIFORMIS. A STUDY WITH ANTIMETABOLITES.
    HOLZ GG; RASMUSSEN L; ZEUTHEN E
    C R Trav Lab Carlsberg; 1963; 33():289-300. PubMed ID: 14060939
    [No Abstract]   [Full Text] [Related]  

  • 37. Symposium on the experimental pharmacology and clinical use of antimetabolites. V. Use of combinations of antimetabolites for chemotherapy of cancer.
    LEPAGE GA
    Clin Pharmacol Ther; 1961; 2():121-9. PubMed ID: 13760996
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of purine and pyrimidine analogues on development of Rana pipiens.
    BIEBER S; NIGRELLI RF; HITCHINGS GH
    Proc Soc Exp Biol Med; 1952 Mar; 79(3):430-2. PubMed ID: 14920451
    [No Abstract]   [Full Text] [Related]  

  • 39. The mechanism of action of hadacidin.
    SHIGEURA HT; GORDON CN
    J Biol Chem; 1962 Jun; 237():1937-40. PubMed ID: 13911879
    [No Abstract]   [Full Text] [Related]  

  • 40. Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites.
    ELION GB; SINGER S; HITCHINGS GH
    J Biol Chem; 1954 Jun; 208(2):477-88. PubMed ID: 13174557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.